MJA
MJA

6: Sexually transmitted infections: new diagnostic approaches and treatments

Med J Aust 2002; 176 (11): 551-557.
  • Francis J Bowden1
  • Sepehr N Tabrizi2
  • Suzanne M Garland3
  • Christopher K Fairley4

  • 1 Canberra Sexual Health Centre, Canberra Hospital, Canberra, ACT.
  • 2 Microbiology and Infectious Diseases, Royal Women's and Children's Hospital, Melbourne, VIC.
  • 3 Melbourne Sexual Health Centre, Melbourne, VIC.

Correspondence: frank.bowden@act.gov.au

  • 1. Communicable Diseases Network Australia — National Notifiable Diseases Surveillance System. Notifications of Chlamydial (NEC) received by State and Territory health authorities in the period of 1991 to 2001 and year-to-date notifications for 2002 by year — month. <http://www.health.gov.au/pubhlth/cdi/nndss/year007.htm> Accessed Apr 2002, no longer available.
  • 2. Schacter J. Biology of Chlamydia trachomatis. In: Holmes KK, Sparling PF, Mardh P-A, et al, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999..
  • 3. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31: 951-957.
  • 4. Tabrizi SN, Chen S, Borg AJ, et al. Patient-administered tampon-collected genital cells in the assessment of Chlamydia trachomatis infection using polymerase chain reaction. Sex Transm Dis 1996; 23: 494-497.
  • 5. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327: 921-925.
  • 6. Stamm W, editor. Chlamydia trachomatis infections of the adult. 3rd ed. Washington: McGraw-Hill, 1999.
  • 7. National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999; 75 Suppl 1: S9-S12.
  • 8. Therapeutic Guidelines Ltd. Therapeutic guidelines: antibiotic. Version 11, 2000. Melbourne: Melbourne: Therapeutic Guidelines Ltd, 2000.
  • 9. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47 (No. RR-1): 1-118.
  • 10. Kani J, Adler M. Epidemiology of pelvic inflammatory disease. In: Berger GS, Westrom L, editors. Pelvic inflammatory disease. New York: Raven Press, 1992: 7.
  • 11. Annual surveillance report: HIV/AIDS, hepatitis C and sexually transmissible infections in Australia. Darlinghurst: National Centre in HIV Epidemiology and Clinical Research, 2000.
  • 12. Farrell DJ. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J Clin Microbiol 1999; 37: 386-390.
  • 13. Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 1999. Commun Dis Intell 2000; 24: 113-117.
  • 14. Bowden FJ, Paterson BA, Mein J, et al. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex Transm Infect 1999; 75: 431-434.
  • 15. Patel SR, Wiese W, Patel SC, et al. Systematic review of diagnostic tests for vaginal trichomoniasis. Infect Dis Obstet Gynecol 2000; 8: 248-257.
  • 16. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487-493.
  • 17. Koutsky LA, Kiviat NB. Genital human papillomavirus. In: Holmes KK, Sparling PF, Mardh P-A, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999: 347-359.
  • 18. Koutsky LA. HPV epidemiology — Gollow Lecture. Abstracts of the Australasian Sexual Health Conference – 2001 . . . a sex odyssey; 2-5 May 2001; Sydney, NSW.
  • 19. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
  • 20. Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PF, Mardh P-A, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999: 285-312.
  • 21. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 1999; 37: 1632-1633.
  • 22. Egglestone SI, Turner AJ. Serological diagnosis of syphilis. PHLS Syphilis Serology Working Group. Commun Dis Public Health 2000; 3: 158-162.
  • 23. Bowden FJ, Bastian I, Johnston F. A community-based approach to the control of sexually transmitted disease in the Northern Territory. Aust N Z J Public Health 1997; 21: 519-523.
  • 24. Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis 1998; 178: 243-246.
  • 25. Gruber F, Kastelan M, Cabrijan L, et al. Treatment of early syphilis with azithromycin. J Chemother 2000; 12: 240-243.
  • 26. Richens J. The diagnosis and treatment of donovanosis (granuloma inguinale). Genitourin Med 1991; 67: 441-452.
  • 27. Carter J, Bowden FJ, Sriprakash KS, et al. Diagnostic polymerase chain reaction for donovanosis. Clin Infect Dis 1999; 28: 1168-1169.
  • 28. Bowden FJ, Mein J, Plunkett C, Bastian I. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med 1996; 72: 17-19.
  • 29. Skov SJ, Tait P, Kaldor J, Bowden FJ. A field trial of azithromycin in the treatment of donovanosis. A step towards eradication? Venereology 1997; 11: 11-14.
  • 30. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342: 534-540.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article